Cargando…
Insights into post-translational processing of β-galactosidase in an animal model resembling late infantile human G(M1)-gangliosidosis
G(M1)-gangliosidosis is a lysosomal storage disorder caused by a deficiency of ß-galactosidase activity. Human GM1-gangliosidosis has been classified into three forms according to the age of clinical onset and specific biochemical parameters. In the present study, a canine model for type II late inf...
Autores principales: | Kreutzer, R, Kreutzer, M, Pröpsting, M J, Sewell, A C, Leeb, T, Naim, H Y, Baumgärtner, W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3918082/ https://www.ncbi.nlm.nih.gov/pubmed/18088383 http://dx.doi.org/10.1111/j.1582-4934.2007.00204.x |
Ejemplares similares
-
Late-infantile GM1 gangliosidosis: A case report
por: Noh, Eu Seon, et al.
Publicado: (2022) -
Synthesis of a New β-Galactosidase Inhibitor Displaying Pharmacological Chaperone Properties for GM1 Gangliosidosis
por: Clemente, Francesca, et al.
Publicado: (2022) -
Intracerebroventricular enzyme replacement therapy with β-galactosidase reverses brain pathologies due to GM1 gangliosidosis in mice
por: Chen, Joseph C., et al.
Publicado: (2020) -
Three novel beta-galactosidase gene mutations in Han Chinese patients with GM1 gangliosidosis are correlated with disease severity
por: Yang, Chi-Fan, et al.
Publicado: (2010) -
1-Deoxy-d-galactonojirimycins with dansyl capped N-substituents as β-galactosidase inhibitors and potential probes for G(M1) gangliosidosis affected cell lines
por: Fröhlich, Richard F.G., et al.
Publicado: (2011)